Cargando…

A pan-cancer analysis revealed the role of the SLC16 family in cancer

Cancer is one of the serious diseases that endanger human health and bring a heavy burden to world economic development. Although the current targeted therapy and immunotherapy have achieved initial results, the emergence of drug resistance shows that the existing research is far from enough. In rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jun, Xie, Jiaheng, Wu, Dan, Chen, Liang, Gong, Zetian, Wu, Rui, Hu, Yiming, Zhao, Jiangning, Xu, Yetao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386723/ https://www.ncbi.nlm.nih.gov/pubmed/34424811 http://dx.doi.org/10.1080/19336950.2021.1965422

Ejemplares similares

Pan-cancer analysis revealed the significance of the GTPBP family in cancer
por: Hu, Yiming, et al.
Publicado: (2022)

Pan-cancer analysis and single-cell analysis revealed the role of ABCC5 transporter in hepatocellular carcinoma
por: Chen, Liang, et al.
Publicado: (2021)

Comprehensive analysis of pan-cancer reveals the potential of SLC16A1 as a prognostic and immunological biomarker
por: Chen, Lingyun, et al.
Publicado: (2023)

Prognostic Value of SLC16A3(MCT4) in Lung Adenocarcinoma and Its Clinical Significance
por: Xue, Lei, et al.
Publicado: (2021)

A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer
por: Liu, Jun, et al.
Publicado: (2021)

Systematic pan-cancer analysis identifies SLC35C1 as an immunological and prognostic biomarker
por: Xie, Mingchen, et al.
Publicado: (2023)

Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics
por: Yu, Shan, et al.
Publicado: (2020)

A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma
por: Gong, Zetian, et al.
Publicado: (2022)

A Pan-Cancer Study of KMT2 Family as Therapeutic Targets in Cancer
por: Zhu, Jiamin, et al.
Publicado: (2022)

A pan-cancer analysis of SLC1A5 in human cancers
por: Ni, Juan, et al.
Publicado: (2023)

A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity
por: Jiang, Yi, et al.
Publicado: (2021)

The pan-cancer landscape of netrin family reveals potential oncogenic biomarkers
por: Hao, Wenjun, et al.
Publicado: (2020)

SLC1A1, SLC16A9, and CNTN3 Are Potential Biomarkers for the Occurrence of Colorectal Cancer
por: Zhou, Jie, et al.
Publicado: (2020)

Methylation Drives SLC2A1 Transcription and Ferroptosis Process Decreasing Autophagy Pressure in Colon Cancer
por: Zou, Junwei, et al.
Publicado: (2022)

Integrative analysis of TRPV family to prognosis and immune infiltration in renal clear cell carcinoma
por: Gong, Zixuan, et al.
Publicado: (2022)

Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer
por: Liu, Ao-ran, et al.
Publicado: (2022)

Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma
por: Xie, Jiaheng, et al.
Publicado: (2021)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of Solute Carrier Family 6 Member 8 (SLC6A8)
por: Yang, Xin, et al.
Publicado: (2022)

Pan‑cancer analysis of the deoxyribonuclease gene family
por: Bai, Qingquan, et al.
Publicado: (2023)

Pan-Cancer Analysis of the COVID-19 Causal Gene SLC6A20
por: Acar, Ahmet
Publicado: (2023)

SLC17A9 expression levels in a pan‑cancer panel and validation of the role of SLC17A9 as a novel prognostic biomarker for osteosarcoma
por: Li, Junqing, et al.
Publicado: (2023)

Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer
por: Sun, Xiaonan, et al.
Publicado: (2023)

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer
por: Zhang, Pei, et al.
Publicado: (2023)

FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis
por: Dong, Qing-Tai, et al.
Publicado: (2023)

Integrated analysis reveals common DNA methylation patterns of alcohol-associated cancers: A pan-cancer analysis
por: Liu, Xingyu, et al.
Publicado: (2023)

The Integrative Analysis of Thrombospondin Family Genes in Pan-Cancer Reveals that THBS2 Facilitates Gastrointestinal Cancer Metastasis
por: Zhang, Chunfeng, et al.
Publicado: (2021)

Mechanistic basis of L-lactate transport in the SLC16 solute carrier family
por: Bosshart, Patrick D., et al.
Publicado: (2019)

Pan‐cancer analyses reveal multi‐omic signatures and clinical implementations of the forkhead‐box gene family
por: Bi, Xiaoman, et al.
Publicado: (2023)

Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Zheng, Haosheng, et al.
Publicado: (2022)

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancer
por: You, Xin, et al.
Publicado: (2023)

Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene SLC7A11 as a Prognostic Biomarker for Cancer
por: Lin, Yi, et al.
Publicado: (2022)

Pan-cancer analyses reveal the immunotherapeutic value of klotho
por: Liang, Jinghao, et al.
Publicado: (2022)

Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment
por: Han, Junwei, et al.
Publicado: (2022)

Combining Single-Cell and Transcriptomic Data Revealed the Prognostic Significance of Glycolysis in Pancreatic Cancer
por: Chen, Liang, et al.
Publicado: (2022)

An Integrative Pan-Cancer Analysis of Kinesin Family Member C1 (KIFC1) in Human Tumors
por: Wu, Hao, et al.
Publicado: (2022)

Pan-Cancer Analysis Reveals the Relation between TRMT112 and Tumor Microenvironment
por: Xu, Haitao, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types
por: Kong, Fan-Sheng, et al.
Publicado: (2023)

Pan-Cancer Analysis Reveals the Functional Importance of Protein Lysine Modification in Cancer Development
por: Chen, Li, et al.
Publicado: (2018)

Integrated Analysis of C16orf54 as a Potential Prognostic, Diagnostic, and Immune Marker across Pan-Cancer
por: Du, Xinna, et al.
Publicado: (2022)

The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance
por: Xie, Jindong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2q045rhvug7pricqb7jikkqp0l